Share this article and save a life!
CVS denied 80% of Medicare post-acute care. That is not a glitch.
Let me say that again.
Eighty percent. 🚨
The Medicare Rights Center published data this week showing that the largest Medicare Advantage organizations have disproportionate denial rates for post-acute care. CVS denied 80% of long-term care hospital coverage. Humana denied 72%. UnitedHealth denied 71%. For inpatient rehab facilities, UnitedHealth led with 66%, Humana at 54%, CVS at 51%.
These are not edge cases. These are the dominant patterns of the dominant players.
Here is my take: this is not a claims processing problem. It is a business model problem.
Medicare Advantage was sold to the public as Medicare, but better. More benefits. Lower costs. A private sector upgrade on a clunky government program. What we actually built is a system where private insurers collect a government capitation check, then systematically deny the care that check was meant to fund.
Post-acute care is not elective. Long-term care hospitals and inpatient rehab facilities treat patients who just had strokes, amputations, cardiac events, traumatic brain injuries. These are not people gaming the system. These are people who just survived something catastrophic and need time and clinical support to recover.
Denying 80% of that coverage is not utilization management. It is a revenue strategy dressed up in clinical language.
And the worst part, we have known this for years. The Office of Inspector General has flagged Medicare Advantage denial patterns repeatedly. CMS has tried to tighten oversight. Congress has held hearings. The numbers keep climbing.
Now the counterpoint. The one I hear from insurer defenders constantly.
“Not every denial is inappropriate. Many are overturned on appeal. Prior authorization exists to prevent wasteful spending.”
Fair. All of that is technically true.
But when 7 in 10 post-acute care claims are being denied by the same three companies, you are not catching outliers. You are setting a default that forces patients, families, and providers to fight for care that should be baseline. Most people do not appeal. They do not have the time, the health, the resources, or the knowledge to navigate that process. Denial by attrition is still denial. 💡
At Oatmeal Health, we work in communities that have been structurally left behind by the healthcare system. Lung cancer screening. Preventive care. Early detection. The people we serve are not going to fight a Medicare Advantage denial letter while recovering from a stroke. They are going to go home too soon and end up back in the ER.
The system counts on that passivity.
The boldest thing I can say here is this: if your denial rate for medically necessary post-acute care is 70 to 80 percent, you are not a health plan. You are a bet that sick people will give up.
Question for every Medicare Advantage plan medical director reading this: at what denial rate does your organization consider the system broken, and who in your company is accountable when a patient goes home too early and dies?
👉 Follow for daily healthcare insights. Deeper dives in The Oatmeal Bite on Substack.
Share this article and save a life!
Author:

CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/




